NASDAQ:KRYS
Krystal Biotech, Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
www.krystalbio.comipo date
Sep 20, 2017
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing KB105 that is in Phase I/II clini...Show More
Earnings
Earnings Release in 9 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus